We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.3B
AUM Growth
-$33M
(-0.17%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,369
New
102
Increased
385
Reduced
639
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$155M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$40.2M |
| 3 |
Starbucks
SBUX
|
+$39.7M |
| 4 |
Citizens Financial Group
CFG
|
+$33.8M |
| 5 |
Robert Half
RHI
|
+$29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$31.8M |
| 2 |
Cardinal Health
CAH
|
+$29.4M |
| 3 |
Dollar General
DG
|
+$27M |
| 4 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$24.6M |
| 5 |
Take-Two Interactive
TTWO
|
+$24.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.13% |
| 2 | Healthcare | 11.9% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Mesa Laboratories
MLAB
$540M
| $22.3M | 0.12% |
73,763
-995
| -1% | -$283K |
|
202
State Street
STT
$50.7B
| $22.2M | 0.11% |
261,538
-6,801
| -3% | -$592K |
|
203
Ziff Davis
ZD
$1.93B
| $22.1M | 0.11% |
186,413
-2,602
| -1% | -$312K |
|
|
SF
204
Stifel
SF
$12.5B
| $22.1M | 0.11% |
487,095
-5,724
| -1% | -$255K |
|
205
Elevance Health
ELV
$82.1B
| $21.9M | 0.11% |
58,769
+4,591
| +8% | +$1.74M |
|
206
Merit Medical Systems
MMSI
$4.54B
| $21.9M | 0.11% |
304,899
-2,249
| -0.7% | -$153K |
|
207
Quest Diagnostics
DGX
$25.6B
| $21.9M | 0.11% |
150,615
-2,622
| -2% | -$384K |
|
208
MasTec
MTZ
$26.6B
| $21.8M | 0.11% |
252,802
-3,460
| -1% | -$328K |
|
209
Prestige Consumer Healthcare
PBH
$2.39B
| $21.8M | 0.11% |
388,495
-4,636
| -1% | -$255K |
|
|
TWNK
210
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $21.7M | 0.11% |
1,250,889
-9,679
| -0.8% | -$157K |
|
211
Ovintiv
OVV
$16.6B
| $21.7M | 0.11% |
658,726
+395,652
| +150% | +$10.9M |
|
212
Hershey
HSY
$36.6B
| $21.6M | 0.11% |
127,708
+16,098
| +14% | +$2.84M |
|
213
Citigroup
C
$223B
| $21.6M | 0.11% |
307,208
+238,546
| +347% | +$16.7M |
|
214
Mettler-Toledo International
MTD
$27B
| $21.5M | 0.11% |
15,582
-837
| -5% | -$1.26M |
|
215
Dollar Tree
DLTR
$24.1B
| $21.3M | 0.11% |
222,987
-196,221
| -47% | -$18.9M |
|
216
Bank of America
BAC
$436B
| $21.3M | 0.11% |
501,418
-51,415
| -9% | -$2.07M |
|
217
Caterpillar
CAT
$402B
| $21.2M | 0.11% |
110,332
+11,126
| +11% | +$2.32M |
|
|
DOOR
218
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $21.1M | 0.11% |
198,423
-2,088
| -1% | -$237K |
|
219
Emcor
EME
$33B
| $21M | 0.11% |
182,095
-2,238
| -1% | -$268K |
|
220
Berkshire Hathaway Class A
BRK.A
$1.07T
| $21M | 0.11% |
51
-9
| -15% | -$3.8M |
|
221
Moody's
MCO
$84.2B
| $20.9M | 0.11% |
58,778
-351
| -0.6% | -$132K |
|
222
MetLife
MET
$61.2B
| $20.4M | 0.11% |
330,061
-2,418
| -0.7% | -$146K |
|
223
Emerson Electric
EMR
$83.6B
| $20.2M | 0.1% |
214,860
-117,887
| -35% | -$11.8M |
|
224
CBRE Group
CBRE
$42.1B
| $20.1M | 0.1% |
206,638
-2,564
| -1% | -$238K |
|
225
KeyCorp
KEY
$24.1B
| $20.1M | 0.1% |
929,246
+263,817
| +40% | +$5.33M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Glenmede Trust held 1,369 positions worth $19.3B, down 0.17% from $19.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q3 2021 filing shows 102 new, 385 increased, 639 reduced and 72 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 5,864,565 shares worth $152M. The largest sale was Johnson & Johnson, an estimated $31.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 5,864,565 shares worth $152M.
- Glenmede Trust added most to Twitter, Inc. in Q3 2021, an estimated $40.2M increase.
- Glenmede Trust's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $31.8M.
- Glenmede Trust fully exited Core Mark Holding Co., Inc. in Q3 2021, selling an estimated $24.6M.
- Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q3 2021.
- Glenmede Trust opened 102 new positions and closed 72 in Q3 2021.
- Glenmede Trust's portfolio value fell 0.17% quarter-over-quarter to $19.3B.
Based on Glenmede Trust's 13F filing for Q3 2021, filed 15 Nov 2021.